The heart is frequently affected by conditions that originate elsewhere in the body, leading to cardiovascular complications in other diseases. For instance, cancer treatments like chemotherapy can damage cardiac tissues, while chronic inflammatory diseases, such as rheumatoid arthritis, elevate the risk of heart attacks. These complications not only worsen a patient’s prognosis but also complicate treatment strategies. Managing cardiovascular risks in patients with systemic diseases demands a collaborative approach between cardiologists and other healthcare providers. From advanced diagnostic tools to innovative therapies, addressing cardiovascular complications in such cases ensures holistic care that reduces mortality and enhances overall well-being.
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Precision nutrition for heart health: A personalized approach to cardiovascular disease prevention and management
Teji Dhami, BOOST your Health and Wellness, United States